The company published trial design and preliminary data from the adaptive DBS algorithm for personalised therapy in Parkinson ...
JPM24: FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s ... green lights near the top of this year ...
Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...
What if we could resist compulsions? These irrational behaviors, particularly common in obsessive-compulsive disorder (OCD), ...
Brian Rust of McFarland, Wisconsin, was diagnosed with an intension tremor and slated for surgery in November 2022. What ...
A team at ETH Zurich is pushing the boundaries of what can be achieved with neurostimulation and neuronal recording ...
12d
Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical ...
Abbott Laboratories will begin clinical trials for its deep-brain stimulation system for treatment-resistant depression after receiving Breakthrough Device designation from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback